Recite me link

1. How many patients were treated by your Trust in the last 3 months with the following drugs:
Adalimumab (Amgevita)
Adalimumab (Humira)
Adalimumab (Hyrimoz)
Adalimumab (Idacio)
Adalimumab (Imraldi)
2. Of the patients treated with Humira in the last 3 months, how many were new to Adalimumab treatment (patients who had not been treated with any brand of Adalimumab in the past year)? If possible please provide new patients number by:
New Humira patients – all departments
New Humira patients – rheumatology
New Humira patients – dermatology
New Humira patients – gastroenterology
3. Of the patients treated with any Adalimumab Biosimilar (Amgevita, Hyrimioz, Idacio, Imraldi etc) in the last 3 months, how many patients were new to Adalimumab treatment (patients who had not been treated with any brand of Adalimumab in the past year)? If possible provide new patients numbers by department:
New Adalimumab Biosimilar patients – all departments
New Adalimumab Biosimilar patients – rheumatology
New Adalimumab Biosimilar patients – dermatology
New Adalimumab Biosimilar patients – gastroenterology

Drug treatments.130522.docx